Company Profile

TOT BIOPHARM-B

1875 Biotechnology
Description

TOT BIOPHARM International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in China. The company develops and markets Pusintin, a bevacizumab injection for the treatment of non-squamous non-small cell lung cancer; metastatic colorectal cancer; recurrent glioblastoma multiforme; epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; cervical cancer; and hepatocellular carcinoma. It also offers Tazian, a temozolomide capsule for the treatment of glioblastoma multiforme or anaplastic astrocytoma; and Megaxia, a megestrol acetate oral suspension for the treatment of anorexia associated with acquired immunode¬ciency syndrome, as well as signi¬cant weight loss of AIDS and cancer patients caused by cachexia. In addition, the company is developing TAB014 that has completed Phase III clinical trial for the treatment of wet age-related macular degeneration (wAMD). Further, it develops products under preclinical trials, including TAE020 for acute myeloid leukemia; and TAC020 for the treatment various solid tumors. Additionally, the company engages in contract development and manufacturing organization (CDMO)/contract manufacture organization (CMO) business; and license-out of self-developed biological drugs. TOT BIOPHARM International Company Limited was incorporated in 2009 and is headquartered in Suzhou, China.

Reports

This company has 2 ESG reports available.

ESG Performance Overview

Select a KPI indicator to view performance trend

KPI Indicators

A1.1 Emission Types and Data
7 Data Points
Indicator Data Points Actions
SOₓ Emissions 1
NOₓ Emissions 3
Airborne Particulate Matter (PM) Emissions 3
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
12 Data Points
Indicator Data Points Actions
Total GHG Emissions Intensity (By Employee) 3
Total GHG Emissions 3
Direct GHG Emissions (Scope 1) 3
Indirect Energy Emissions (Scope 2) 3
A1.3 Hazardous Waste
6 Data Points
Indicator Data Points Actions
Total Hazardous Waste Intensity (By Employee) 3
Total Hazardous Waste 3
A1.4 Non-Hazardous Waste
9 Data Points
Indicator Data Points Actions
Non-Hazardous Waste Recycled 3
Non-Hazardous Waste (Domestic Waste) 3
Total Non-Hazardous Waste Intensity (By Employee) 3

A2.1 Energy Consumption
21 Data Points
Indicator Data Points Actions
Energy Consumption Intensity (By Employee) 3
Total Energy Consumption 3
Total Direct Energy Consumption 3
Diesel Fuel Consumption 3
Natural Gas Consumption 3
Total Indirect Energy Consumption 3
Purchased Electricity 3
A2.2 Water Consumption
5 Data Points
Indicator Data Points Actions
Water Consumption 2
Recycled Water Usage 2
Water Consumption Intensity (By Revenue) 1
A2.3 Energy Use Efficiency Targets
1 Data Points
Indicator Data Points Actions
Energy Consumption Reduction Compared to Last Year 1
A2.4 Water Efficiency Targets
2 Data Points
Indicator Data Points Actions
Water Consumption Reduction Compared to Last Year 2
A2.5 Total Packaging Material Used
1 Data Points
Indicator Data Points Actions
Packaging Materials Consumed 1

B1.1 Amount and Distribution of Workforce
35 Data Points
Indicator Data Points Actions
Number of Total Employees 2
Number of Male Employees 2
Number of Female Employees 2
Percentage of Male Employees 2
Percentage of Female Employees 2
Number of Employees Aged Below 30 2
Number of Employees Aged 30-50 2
Number of Employees Aged Above 50 2
Percentage of Employees Aged Below 30 2
Percentage of Employees Aged 30-50 2
Percentage of Employees Aged Above 50 2
Number of Employees in Mainland China 1
Number of Employees in Hong Kong and Mainland China 1
Number of Employees in Overseas 1
Percentage of Employees in Mainland China 2
Percentage of Employees in Hong Kong and Mainland China 1
Percentage of Employees in Overseas 2
Percentage of Senior Management Employees 1
Percentage of Middle Management Employees 1
Percentage of General Employees 1
Number of New Employees 1
Percentage of New Employees 1
B1.2 Employee Turnover Rate
5 Data Points
Indicator Data Points Actions
Turnover Rate of Employees Aged Below 30 1
Turnover Rate of Employees Aged 30-50 1
Turnover Rate of Employees Aged Above 50 1
Turnover Rate of Employees in Hong Kong 1
Turnover Rate of Employees in Mainland China 1

B2.1 Number and Rate of Work-related Fatalities
4 Data Points
Indicator Data Points Actions
Number of Work-related Fatalities 1
Number of Fatalities as a Result of Work-related Injuries 1
Number of Work-related Fatalities for Contractors 1
Number of Work-related Fatalities for Direct Employee 1
B2.3 Occupational Health and Safety Measures Adopted
2 Data Points
Indicator Data Points Actions
Number of People Receiving Training on Work Safety 1
Participation Rate of Safety Training 1

B3.1 The Percentage of Employees Trained
10 Data Points
Indicator Data Points Actions
Percentage of Trained Male Employees 2
Percentage of Trained Female Employees 2
Percentage of Trained Senior Management 2
Percentage of Trained Middle Management 2
Percentage of Trained General Employees 2
B3.2 Average Training Hours Completed per Employee
12 Data Points
Indicator Data Points Actions
Total Training Hours 1
Average Training Hours per Employee 1
Average Training Hours (Male) 2
Average Training Hours (Female) 2
Average Training Hours (Senior Management) 2
Average Training Hours (Middle Management) 2
Average Training Hours (General Staff) 2

B5.1 Number of Suppliers by Geographical Region
1 Data Points
Indicator Data Points Actions
Number of Total Suppliers 1

B6.1 Products Recalled
2 Data Points
Indicator Data Points Actions
Percentage of Recalled Products for Safety and Health Reasons 1
Number of Recalled Products for Safety and Health Reasons 1
B6.3 Protection on Intellectual Property Rights
4 Data Points
Indicator Data Points Actions
Number of Patents Held 1
Number of Invention Patents 1
Number of Trademark Registrations 1
Number of Authorised Utility Model Patents 1
B6.4 Quality Assurance Process and Recall Procedures
1 Data Points
Indicator Data Points Actions
Number of Training Employees on Quality and Safety 1

B8.2 Resources Contributed to the Community
4 Data Points
Indicator Data Points Actions
Total Public Welfare Donations 1
Total In-kind Donations 3

ESG Reports

Year Report Title Publication Date Raw KPIs Standard KPIs Processed Actions
2020 2020 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) REPORT 2021-06-29 114 85 Yes
2019 2019 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) REPORT 2020-07-01 90 59 Yes